Enanta Pharmaceuticals Inc. sell Global_Player
Start price
29.09.25
/
50%
€11.40
Target price
29.09.26
-
Performance (%)
-20.61%
End price
01.10.25
€9.05
Summary
This prediction ended on 01.10.25 with a price of €9.05. The prediction for Enanta Pharmaceuticals Inc. closed with a convincing performance of -20.61%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Enanta Pharmaceuticals Inc. | 3.817% | 3.817% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
According to Global_Player what are the pros and cons of Enanta Pharmaceuticals Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Global_Player for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Sell Enanta Pharmaceuticals Inc.